PT-141: mechanism of action and potential benefits
PT-141, also known as bremelanotide, is a melanocortin receptor agonist that acts mainly through central nervous-system pathways involved in sexual motivation and arousal rather than through direct blood-vessel dilation.
99%+ HPLC purity
Batch COA records
QR vial verification
Scientific product profiles
Mechanism of action
It activates melanocortin receptors, especially MC4R, in hypothalamic and limbic circuits. These pathways influence sexual desire and arousal signaling upstream of the peripheral vascular response.
Potential benefits
May increase sexual desire
May strengthen central arousal signaling
Works through neural rather than primarily vascular pathways
May support sexual response when low desire is a central factor
Evidence context: Central melanocortin activity is well described, but individual effects and adverse responses can vary substantially.
Product data and verification
DEU Peptides connects the PT-141 catalog entry with identity, purity, storage, and batch data. A registered QR code can confirm the product name, concentration, batch ID, vial ID, and date fields.
It activates melanocortin receptors, especially MC4R, in hypothalamic and limbic circuits. These pathways influence sexual desire and arousal signaling upstream of the peripheral vascular response.
What potential benefits are associated with PT-141?
May increase sexual desire; May strengthen central arousal signaling; Works through neural rather than primarily vascular pathways; May support sexual response when low desire is a central factor.
How strong is the evidence for PT-141?
Central melanocortin activity is well described, but individual effects and adverse responses can vary substantially.
This scientific overview is general information and does not replace individualized medical advice, diagnosis, or treatment.